Evidence map›Paper›PMID 22585548›Full record

ArticleEuropean journal of immunology2012

CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates.

Gabrielle Romain, Ellen van Gulck, Olivier Epaulard, Sangkon Oh, Dapeng Li, Gerard Zurawski, Sandra Zurawski, Antonio Cosma, Lucille Adam, Catherine Chapon and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. mRNA-based HIV-1 vaccines.Clinical microbiology reviews · 2024
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Gabrielle RomainCEA, Division of Immuno-Virology, Institute for Emerging Diseases and Innovative Therapies, DSV, Fontenay-aux-Roses, France.
Ellen van Gulck
Olivier Epaulard
Sangkon Oh
Dapeng Li
Gerard Zurawski
Sandra Zurawski
Antonio Cosma
Lucille Adam
Catherine Chapon
Biliana Todorova
Jacques Banchereau
Nathalie Dereuddre-Bosquet
Guido Vanham
Roger Le Grand
Frédéric Martinon
Inserm · FRInfectious Disease Models and Innovative Therapies · FRUniversité Paris-Sud · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInstituut voor Tropische Geneeskunde · BEBaylor University · USCEA Paris-Saclay - Etablissement de Fontenay-aux-roses · FR

Funding

Targeting Dendritic Cells for Enhanced Musocal ImmunityU19AI057234 · NIAID · BAYLOR RESEARCH INSTITUTE · PI LEGRAND, ROGER · 2003 to 2013
$49.2M
NIAID NIH HHS 2U19AI057234-06NIAID NIH HHS U19 AI057234
6 · The paper itself

Abstract

The pivotal role of DCs in initiating immune responses led to their use as vaccine vectors. However, the relationship between DC subsets involved in antigen presentation and the type of elicited immune responses underlined the need for the characterization of the DCs generated in vitro. The phenotypes of tissue-derived APCs from a cynomolgus macaque model for human vaccine development were compared with ex vivo-derived DCs. Monocyte/macrophages predominated in bone marrow (BM) and blood. Myeloid DCs (mDCs) were present in all tested tissues and were more highly represented than plasmacytoid DCs (pDCs). As in human skin, Langerhans cells (LCs) resided exclusively in the macaque epidermis, expressing CD11c, high levels of CD1a and langerin (CD207). Most DC subsets were endowed with tissue-specific combinations of PRRs. DCs generated from CD34(+) BM cells (CD34-DCs) were heterogeneous in phenotype. CD34-DCs shared properties (differentiation and PRR) of dermal and epidermal DCs. After injection into macaques, CD34-DCs expressing HIV-Gag induced Gag-specific CD4(+) and CD8(+) T cells producing IFN-γ, TNF-α, MIP-1β, or IL-2. In high responding animals, the numbers of polyfunctional CD8(+) T cells increased with the number of booster injections. This DC-based vaccine strategy elicited immune responses relevant to the DC subsets generated in vitro.

Indexed as

Lymphocyte ActivationAdaptor Proteins, Signal TransducingAnimalsAntigen PresentationAntigens, CDAntigens, CD1Antigens, CD34Bone Marrow CellsCD11c AntigenCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationDendritic Cellsgag Gene Products, Human Immunodeficiency VirusInterferon-gammaInterleukin-2Adaptor Proteins, Signal TransducingAntigens, CDAntigens, CD1Antigens, CD34CD11c AntigenCD207 protein, humangag Gene Products, Human Immunodeficiency VirusInterferon-gammaInterleukin-2Lectins, C-TypeMannose-Binding LectinsRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID22585548
PMCPMC3649569
OpenAlexW1510510756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.